Photo available in the Archive Image Gallery or direct download High Res. Image, Electronic Media Mail Image
How do the French get away with a clean bill of heart health
despite a diet loaded with saturated fats? Scientists have long suspected that the
answer to the so-called "French paradox" lies in red wine. Now, the results of
a new study bring them closer to understanding why.
Writing this week in the online, open-access journal Public
Library of Science (PLoS) ONE, researchers from industry and academia,
including the University of Wisconsin-Madison and the University of Florida, report
that low doses of resveratrol — a natural constituent of grapes, pomegranates,
red wine and other foods — can potentially boost the quality of life by
improving heart health in old age.
The scientists included small amounts of resveratrol in the
diets of middle-aged mice and found that the compound has a widespread
influence on the genetic causes of aging. Specifically, the researchers found
that low doses of resveratrol mimic the heart-healthy effects of what is known
as caloric restriction, diets with 20 to 30 percent fewer calories than a
typical diet. The new study is important because it suggests that resveratrol
and caloric restriction, which has been widely studied in animals from spiders
to humans, may govern the same master genetic pathways related to aging.
"Caloric restriction is highly effective in extending life
in many species. If you provide species with less food, the regulated cellular
stress response of this healthy habit actually makes them live longer," says study
author Christiaan Leeuwenburgh, Ph.D., chief of the division of biology of
aging at UF's Institute on Aging. "In this study, the effects of low doses of resveratrol
(on genes) were comparable to caloric restriction, the hallmark for life
extension."
Previous research has shown that high doses of resveratrol extend
life in invertebrates and prevent early death in mice given a high-fat diet. The
new study extends those findings, showing that resveratrol in low doses, beginning
in middle age, can elicit many of the same benefits as a reduced-calorie diet.
"Resveratrol is active in much lower doses than previously
thought," said Tomas Prolla, a UW professor of genetics and a senior author of
the new report.
The group explored the agent's influence on the heart,
muscle and brain by looking to see which genes were switched on and off during
the aging process.
In the new study — which compared the genetic responses of
animals to either restricted diets or normal diets including small doses of
resveratrol — the similarities were remarkable, explains lead author Jamie
Barger of Madison, Wis.-based LifeGen Technologies, who spearheaded the research.
In the heart, for example, there are at least 1,029 genes whose functions change with age. In animals on restricted diets, 90 percent of those heart genes experienced alterations in gene expression, while low doses
of resveratrol thwarted age-related change in 92 percent. The new findings, say the study's authors, reveal how red wine's special ingredient helps keep the
heart young.
In short, the authors note that a glass of wine or food or
supplements containing even small doses of resveratrol are likely to help stave
off cardiac aging.
That finding, may also explain the remarkable heart health
of people who live in some regions of France
where diets are soaked in saturated fats but the incidence of heart disease, a
major cause of mortality in the United
States, is low. In France, meals
are traditionally complemented with a glass of red wine.
"There must be a few master biochemical pathways activated
in response to caloric restriction, which in turn activate many other pathways,"
explained Prolla. "And resveratrol seems to activate some of these master
pathways as well."
Resveratrol is currently sold over-the-counter as a
nutritional supplement with supposed anti-cancer, anti-viral, anti-inflammatory
and anti-aging benefits, although few scientific studies have verified these
claims in humans. That may soon change: Researchers at the University of Florida
hope to explore the effects of resveratrol on older people in a phase 1 clinical
trial, set to begin this summer.
The study will assess the supplement's effects on memory,
physical performance, inflammation and oxidative damage, according to Steve
Anton, Ph.D., a principal investigator of the upcoming trial and an assistant
professor of aging and geriatrics in the UF College of Medicine.
Mitochondria, the tiny power plants that keep a cell
functioning, are especially vulnerable to the oxidative damage that accumulates
during the aging process.
"In animal studies, (resveratrol) seems to promote
mitochondrial health," said Todd Manini, Ph.D., also a principal investigator
of the upcoming trial and an assistant professor of aging and geriatrics in the
UF College of Medicine. "Mitochondria are everywhere: They're in the brain, in
the muscle, the liver. So it could have kind of a global impact on many
different organ systems."